Dr. Matthew D. Cheney
Claim this profileMaine Medical Center- Scarborough Campus
Area of expertise
Breast Cancer
Matthew D. Cheney has run 5 trials for Breast Cancer. Some of their research focus areas include:
Prostate Adenocarcinoma
Matthew D. Cheney has run 5 trials for Prostate Adenocarcinoma.
Affiliated Hospitals
Maine Medical Center- Scarborough Campus
MaineHealth Cancer Care Center Of York County
Clinical Trials Matthew D. Cheney is currently running
Chemotherapy + Radiotherapy
for Esophageal and Gastric Cancer
This phase III trial studies how well the addition of radiotherapy to the usual treatment (chemotherapy) works compared to the usual treatment alone in treating patients with esophageal and gastric cancer that has spread to a limited number of other places in the body (oligometastatic disease). Radiotherapy uses high energy x-rays, gamma rays, or protons to kill tumor cells and shrink tumors. Drugs used in usual chemotherapy, such as leucovorin, 5-fluorouracil, oxaliplatin, and capecitabine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Adding radiotherapy to the usual chemotherapy may work better compared to the usual chemotherapy alone in treating patients with esophageal and gastric cancer.
Recruiting
2 awards
Phase 3
20 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting
2 awards
Phase 3
19 criteria
More about Matthew D. Cheney
Clinical Trial Related
5 years of experience running clinical trials · Led 22 trials as a Principal Investigator · 9 Active Clinical Trials
Treatments Matthew D. Cheney has experience with
- Radiation Therapy
- Intensity-Modulated Radiation Therapy
- Cisplatin
- Fluorouracil
- Nivolumab
- Bicalutamide
Breakdown of trials Matthew D. Cheney has run
Breast Cancer
Prostate Adenocarcinoma
Prostate Cancer
Brain Tumor
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew D. Cheney specialize in?
Matthew D. Cheney focuses on Breast Cancer and Prostate Adenocarcinoma. In particular, much of their work with Breast Cancer has involved Stage II patients, or patients who are Stage I.
Is Matthew D. Cheney currently recruiting for clinical trials?
Yes, Matthew D. Cheney is currently recruiting for 9 clinical trials in Scarborough Maine. If you're interested in participating, you should apply.
Are there any treatments that Matthew D. Cheney has studied deeply?
Yes, Matthew D. Cheney has studied treatments such as Radiation Therapy, Intensity-Modulated Radiation Therapy, Cisplatin.
What is the best way to schedule an appointment with Matthew D. Cheney?
Apply for one of the trials that Matthew D. Cheney is conducting.
What is the office address of Matthew D. Cheney?
The office of Matthew D. Cheney is located at: Maine Medical Center- Scarborough Campus, Scarborough, Maine 04074 United States. This is the address for their practice at the Maine Medical Center- Scarborough Campus.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.